Devices › Device types
FDA product code BSZ · class 2 · Anesthesiology
Gas-machine, anesthesia: medical device reports filed with FDA
48,583 reports carry this product code, 1992–2026; 30 brands with a page.
- 48,583
- reports with this product code
- 0.2% of all MAUDE reports
- 8,590
- reports, 12 months to August 2026
- 8,356 in the 12 months before
- 97.9%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code BSZ is FDA's classification for "Gas-machine, anesthesia" (anesthesiology panel), a class 2 device. 48,583 medical device reports carry this product code, 0.2% of the MAUDE database, from July 1992 to August 2026.
8,590 reports arrived in the 12 months to August 2026, close to the 8,356 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (97.9%), injury (1.5%) and other (0.3%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Carestation 650 | 6,152 | 1,686 | 0% | 99.8% |
| Avance | 5,972 | 1,353 | 0.1% | 99.2% |
| Aisys | 5,273 | 1,531 | 0.1% | 98.7% |
| Carestation 620 | 4,352 | 1,402 | 0% | 99.9% |
| Aisys Cs2 | 3,105 | 4 | 0.1% | 99.1% |
| Avance Cs2 | 2,937 | 3 | 0.2% | 99.2% |
| Aespire 7100 | 2,777 | 3 | 0.1% | 99.8% |
| Carestation 750 | 2,540 | 1,042 | 0% | 99.8% |
| Aespire 7900 | 2,039 | 11 | 0.2% | 99.6% |
| Aespire View | 1,729 | 10 | 0.1% | 99.5% |
| Aespire | 1,362 | 564 | 0.1% | 99.4% |
| Aestiva 7900 | 1,160 | 2 | 0% | 99.6% |
| Aestiva 7100 | 860 | 0 | 0% | 99.5% |
| Aestiva | 789 | 329 | 0.1% | 98.2% |
| Flow-I | 581 | 0 | 0% | 91.9% |
| Carestation 650 A1 | 479 | 10 | 0% | 100% |
| Aestiva Mri | 464 | 4 | 0.2% | 98.7% |
| Apollo | 425 | 141 | 1.8% | 84.1% |
| Primus | 424 | 42 | 1.9% | 88.3% |
| Flow-i C20 | 391 | 55 | 0% | 94.4% |
| Carestation 620 A1 | 247 | 0 | 0% | 100% |
| Narkomed | 226 | 0 | 5.3% | 72.7% |
| Adu | 224 | 0 | 0% | 96.9% |
| Perseus A500 | 213 | 42 | 2.1% | 88.6% |
| Fabius GS | 195 | 7 | 1.6% | 87.4% |
| Fabius Tiro | 189 | 28 | 1% | 95.7% |
| Fabius GS Premium | 157 | 19 | 1.1% | 93.7% |
| Kion | 135 | 0 | 0% | 96.3% |
| Evita | 102 | 0 | 7.1% | 86.8% |
| Carescape R860 | 30 | 50 | 0.2% | 99.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Datex-Ohmeda | 32,142 | 66.2% |
| Ge Medical Systems China Wuxi | 8,483 | 17.5% |
| Ge Medical Systems China | 2,212 | 4.6% |
| Maquet Critical Care | 1,469 | 3% |
| Draeger Medical | 516 | 1.1% |
| Mindray Ds USA | 213 | 0.4% |
| Ge Healthcare | 128 | 0.3% |
| Spacelabs Healthcare | 79 | 0.2% |
| Draeger Medical Systems | 48 | 0.1% |
| Ge Medical Systems | 27 | 0.1% |
| Datascope | 6 | 0% |
| Abbott Laboratories | 1 | 0% |
| Bard Access Systems | 1 | 0% |
| Dentsply Tulsa | 1 | 0% |
| Maquet | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Therapeutic or diagnostic output failure | 7,158 | 14.7% |
| Mechanical problema mechanical problem | 4,815 | 9.9% |
| No flow | 4,293 | 8.8% |
| Failure to run on battery | 4,053 | 8.3% |
| Insufficient flow or under infusion | 2,582 | 5.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 1,790 | 3.7% |
| No display/image | 1,775 | 3.7% |
| Power problem | 1,685 | 3.5% |
| Electrical /electronic property probleman electrical or electronic problem | 1,460 | 3% |
| Unexpected therapeutic results | 1,447 | 3% |
| Failure to deliverthe device did not deliver the dose or item | 1,407 | 2.9% |
| Gas/air leak | 1,336 | 2.7% |
| Output problem | 1,291 | 2.7% |
| Gas output problem | 1,124 | 2.3% |
| Increase in pressure | 1,101 | 2.3% |
| Unexpected shutdown | 956 | 2% |
| Device displays incorrect message | 853 | 1.8% |
| Infusion or flow problema problem with flow or infusion | 803 | 1.7% |
| Leak/splashthe device leaked | 773 | 1.6% |
| Device alarm system | 714 | 1.5% |
Questions about gas-machine, anesthesia reports
What is product code BSZ?
FDA's classification code for "Gas-machine, anesthesia", class 2, reviewed by the anesthesiology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
48,583 reports through August 2026, 8,590 of them in the latest 12 months.
Which brands appear most often?
Carestation 650 (6,152), Avance (5,972), Aisys (5,273), Carestation 620 (4,352) and Aisys Cs2 (3,105). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.